Quality by Design characterization of the perfusion culture process for recombinant FVIII-Reference-Cited by-同舟云学术

Quality by Design characterization of the perfusion culture process for recombinant FVIII

Published:2019-05 Issue: Volume:59 Page:37-46
ISSN:1045-1056
Container-title:Biologicals
language:en
Short-container-title:Biologicals

Author:

Kim Yong Jae,Paik Sang Hoon,Han Sang Kyul,Lee Sunggeun,Jeong Yoomin,Kim Ji-youn,Kim Chan Wha

Funder

GC Pharma

Publisher

Elsevier BV

Subject

Pharmacology,General Immunology and Microbiology,Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Reference45 articles.

1. Production processes of licensed recombinant factor VIII preparations;Boedeker;Semin Thromb Hemost,2001

2. Purification of recombinant human B-Domain-Deleted factor VIII using anti-factor VIII monoclonal antibody selected by the surface plasmon resonance biosensor;Oh;Biotechnol Prog,2001

3. Manufacturing process used to produce long-acting recombinant factor VIII Fc fusion protein;McCue;Biologicals,2015

4. Expression of factor VIII in recombinant and transgenic systems;Soukharev;Blood Cells Mol Dis,2002

5. The new albumin-free recombinant factor VIII concentrates for treatment of hemophilia: do they represent an actual incremental improvement?;Josephson;Clin Adv Hematol Oncol,2004

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An innovative hybrid modeling approach for simultaneous prediction of cell culture process dynamics and product quality;Biotechnology Journal;2024-03

2. Current challenges and recent advances on the path towards continuous biomanufacturing;Biotechnology Progress;2023-07-26

3. Optimization of an adenovirus-vectored zoster vaccine production process with chemically defined medium and a perfusion system;Biotechnology Letters;2022-10-01

4. Perfusion culture of Chinese Hamster Ovary cells for bioprocessing applications;Critical Reviews in Biotechnology;2021-11-29

5. Critical Analysis of cGMP Large-Scale Expansion Process in Bioreactors of Human Induced Pluripotent Stem Cells in the Framework of Quality by Design;BioDrugs;2021-11